Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
AIDS (London, England)
|
March 10, 2026
Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort
Jesús Troya, María Luisa Montes, María José Galindo, et al.
AIDS (London, England)
|
November 3, 2025
Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort
Luis Buzón, José I Bernardino, María José Galindo Puerto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2022
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Rocío Montejano, Fernando de la Calle-Prieto, María Velasco, et al.
The Lancet. HIV
|
June 9, 2025
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
Pablo Ryan, José L Blanco, Mar Masia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2024
A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19
Pedro Landete, Olga-Adriana Caliman-Sturdza, Jose A Lopez-Martin, et al.
Medicina Clinica
|
December 19, 2002
[Retrospective epidemiological study on the durability of the treatment of HIV infection or AIDS in Spain]
José Ramón Arribas López, Susana Sanz Baena, Susana Hernández Albujar, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 2, 2021
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Life Science Alliance
|
January 11, 2022
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
Jose F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
April 9, 2016
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
José Antonio Iribarren, Rafael Rubio, Koldo Aguirrebengoa, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
March 16, 2016
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
José Antonio Iribarren, Rafael Rubio, Koldo Aguirrebengoa, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
AIDS (London, England)
|
March 10, 2026
Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort
Jesús Troya, María Luisa Montes, María José Galindo, et al.
AIDS (London, England)
|
November 3, 2025
Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort
Luis Buzón, José I Bernardino, María José Galindo Puerto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2022
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Rocío Montejano, Fernando de la Calle-Prieto, María Velasco, et al.
The Lancet. HIV
|
June 9, 2025
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
Pablo Ryan, José L Blanco, Mar Masia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2024
A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19
Pedro Landete, Olga-Adriana Caliman-Sturdza, Jose A Lopez-Martin, et al.
Medicina Clinica
|
December 19, 2002
[Retrospective epidemiological study on the durability of the treatment of HIV infection or AIDS in Spain]
José Ramón Arribas López, Susana Sanz Baena, Susana Hernández Albujar, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 2, 2021
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Life Science Alliance
|
January 11, 2022
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
Jose F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
April 9, 2016
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
José Antonio Iribarren, Rafael Rubio, Koldo Aguirrebengoa, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
March 16, 2016
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
José Antonio Iribarren, Rafael Rubio, Koldo Aguirrebengoa, et al.
Page
of 8